As usual to each New Year, the annual review of Iran J Public Health, hereby is presented for the year 2018. Besides, this editorial will compare the trend of whole publication process during 2015--2018.

The total number of manuscripts received during 2018 was 2540 from 60 countries. Of course, only the country of corresponding author was considered, so altogether much more countries we had in the panel. Again, Iran had the highest rate of submission, followed by China and South Korea ([Table 1](#T1){ref-type="table"}) ([Fig. 1](#F1){ref-type="fig"}). [Figure 2](#F2){ref-type="fig"} presents total number of articles published during 2015--18 in the context of the frequency of submission, rejection and acceptance rate.
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###### 

Frequency of manuscripts received by Iran J Public Health during 2018 in terms of the frequency of submission, rejection and acceptance rate

  **No.**   **Country**         **Submitted**   **Rejected**   **Accepted**
  --------- ------------------- --------------- -------------- --------------
  **1**     **Afghanistan**     1                              
  **2**     **Albania**         1               0              1
  **3**     **Algeria**         1               \-             \-
  **4**     **Armenia**         1               0              1
  **5**     **Australia**       2               2              0
  **6**     **Bangladesh**      4               1              2
  **7**     **Belgium**         1               1              0
  **8**     **Brazil**          13              9              3
  **9**     **Bulgaria**        9               6              3
  **10**    **Burkina Faso**    1               1              0
  **11**    **Canada**          1               1              0
  **12**    **Czech**           1               0              1
  **13**    **China**           369             265            75
  **14**    **Colombia**        1               0              1
  **15**    **Cyprus**          5               \-             \-
  **16**    **Egypt**           6               6              0
  **17**    **Ethiopia**        1               \-             \-
  **18**    **Ghana**           1               0              1
  **19**    **Greece**          4               3              0
  **20**    **Hong Kong**       1               \-             \-
  **21**    **India**           21              21             0
  **22**    **Indonesia**       61              53             8
  **23**    **Iran**            1322            1071           172
  **24**    **Iraq**            21              21             0
  **25**    **Italy**           3               3              0
  **26**    **Japan**           8               0              4
  **27**    **Jordan**          8               8              0
  **28**    **Kazakhstan**      16              9              6
  **29**    **Korea**           96              49             37
  **30**    **Kuwait**          2               2              0
  **31**    **Lebanon**         1               1              0
  **32**    **Macedonia**       1               0              1
  **33**    **Malaysia**        43              27             13
  **34**    **Mexico**          1               1              0
  **35**    **Montenegro**      2               1              1
  **36**    **Morocco**         11              8              3
  **37**    **Myanmar**         1               1              0
  **38**    **Nepal**           1               1              0
  **39**    **Nigeria**         9               9              0
  **40**    **Pakistan**        87              75             10
  **41**    **Palestinian**     5               5              0
  **42**    **Poland**          16              9              6
  **43**    **Qatar**           1               1              0
  **44**    **Romania**         26              22             4
  **45**    **Russia**          6               4              0
  **46**    **Saudi Arabia**    9               9              0
  **47**    **Serbia**          29              19             7
  **48**    **Slovakia**        8               0              8
  **49**    **Slovenia**        1               0              1
  **50**    **South Africa**    5               4              0
  **51**    **Spain**           2               0              1
  **52**    **Sri Lanka**       1               0              1
  **53**    **Syria**           2               2              0
  **54**    **Taiwan**          2               2              0
  **55**    **Thailand**        4               3              1
  **56**    **Tunisia**         9               8              1
  **57**    **Turkey**          264             245            12
  **58**    **Ukraine**         2               2              0
  **59**    **United States**   7               5              2
  **60**    **Vietnam**         2               2              0
            **Total**           2540            2005           387

Out of total submission of 2540 articles during 2018, 2005 articles were rejected after initial in-house evaluation or later peer review. Therefore the acceptance rate for this year was 15.2%.

In 2018, still we had unfortunately noticed some cases of plagiarism, which were treated according to the journal policy and COPE instructions. Normally, authors of minor cases of plagiarism are given a chance to amend their manuscripts precisely but major cases are rejected.

The Journal continued its policy as for exact peer review rules including in-house evaluation followed by double blind peer review system. The reasons for rejecting a manuscript during in-house evaluation are various but the most important cases are out of scope cases, poor outcome, local studies, clinical contents etc. [Figure 3](#F3){ref-type="fig"}, demonstrates the total number of articles published during 2015--2018 in terms of the percent of acceptance and rejection rate. It is worth mentioning that some manuscripts submitted during 2018, are still in the process of peer review so we have no idea of their destination. However, the rejection rate in 2018 was 79%.
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The types of articles published during 2015--2018 are shown in [Fig. 4](#F4){ref-type="fig"}. Accordingly, Original Articles had the highest rate of publication during the last four years.
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Due to high flow of submitted manuscripts, in many cases, the authors were requested to change the format of "Original Article" to "Letter to the Editor", which of course the merit of both formats remains the same.

According to <http://www.scimagojr.com/>, the H index of the journal is 24 until 2017. Besides, SCOPUS has reported the Site Score of the journal as 0.85 for 2017, besides SNIP as 0.6788.

The good news for us and respected authors was that the Impact Factor announced by Clarivate Analytics (ISI) for the year 2017 was 1.053. In comparison to previous years, fortunately we had a great improvement on the journal quality. We should respect all referees and authors from all over the world to cooperate with us sincerely and caused their journal to further its aims. We do hope in near future, to improve this rate as much as possible ([Fig. 5](#F5){ref-type="fig"}). This figure shows some key indicators reported by Clarivate Analytics during 2008--17.
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